吉利德科学Gilead Sciences (GILD) 2004年年度报告「NASDAQ」.pdf

1、 SECURITIES AND EXCHANGE COMMISSION Washington,D.C.20549 FORM 10-K (Mark One)ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31,2004 or?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For t

2、he transition period from to Commission File No.0-19731 GILEAD SCIENCES,INC.(Exact name of registrant as specified in its charter)SECURITIES REGISTERED PURSUANT TO SECTION 12(b)OF THE ACT:NONE SECURITIES REGISTERED PURSUANT TO SECTION 12(g)OF THE ACT:COMMON STOCK$.001 PAR VALUE (Title of Class)Indic

3、ate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the Registrant was required to file such reports),and(2)has been subject to such filing re

4、quirements for the past 90 days.Yes No?Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K(Section 229.405 of this chapter)is not contained herein,and will not be contained,to the best of registrants knowledge,in definitive proxy or information statements

5、 incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.?Indicate by check mark whether registrant is an accelerated filer(as defined in Rule 12B-2 of the Act).Yes No?The aggregate market value of the voting stock held by non-affiliates of the registrant based upo

6、n the closing price of the Common Stock on the Nasdaq Stock Market on June 30,2004 was$14,064,813,000.*The number of shares outstanding of the Registrants Common Stock on February 28,2005 was 449,881,860.*DOCUMENTS INCORPORATED BY REFERENCE Specified portions of Registrants Definitive Proxy Statemen